AGS Beers Criteria Practice Test 2026 – The Complete All-in-One Guide to Exam Success!

The main idea is that direct oral anticoagulants offer at least as good protection against stroke or VTE as warfarin in older adults, but with a safer bleeding profile overall. Warfarin has a narrow therapeutic window and is highly sensitive to drug and food interactions, plus it requires regular INR monitoring and dose adjustments. In older patients, this makes stable anticoagulation harder to achieve, increasing the chances of periods of over-anticoagulation and major bleeding. Direct oral anticoagulants, by contrast, have more predictable effects, fewer interactions, and fixed dosing, which generally leads to lower rates of major bleeding—especially intracranial hemorrhage—while not compromising, and often preserving or improving, effectiveness in preventing thromboembolism. There can be concern about GI bleeding with some DOACs, but the overall bleeding risk tends to be lower with DOACs, and the net clinical benefit in many older patients is greater.